BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9863709)

  • 1. In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Pourtau J; Soria C; Paysant J; Vannier JP; Vasse M
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):609-15. PubMed ID: 9863709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.
    van den Eijnden-Schrauwen Y; Atsma DE; Lupu F; de Vries RE; Kooistra T; Emeis JJ
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2177-87. PubMed ID: 9351387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M induces tissue-type plasminogen activator and plasminogen activator inhibitor-1 in Calu-1 lung carcinoma cells.
    Spence MJ; Streiff R; Day D; Ma Y
    Cytokine; 2002 Apr; 18(1):26-34. PubMed ID: 12090757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
    Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukaemia inhibitory factor and oncostatin M modulate expression of urokinase plasminogen activator and fibrinogen.
    Okada H; Woodcock-Mitchell J; Fujii S
    Coron Artery Dis; 1996 Aug; 7(8):561-7. PubMed ID: 8922882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced secretion of tissue plasminogen activator by simultaneous use of retinoic acid and ascorbic acid from tissue cultured gastroepiploic artery.
    Yoshino A; Suzuki K; Urano T; Aoki K; Takada Y; Kazui T; Takada A
    Life Sci; 2002 Feb; 70(12):1461-70. PubMed ID: 11883720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
    van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
    Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ -regulated secretion of tissue-type plasminogen activator and von Willebrand factor in human endothelial cells.
    Knop M; Gerke V
    Biochim Biophys Acta; 2002 Nov; 1600(1-2):162-7. PubMed ID: 12445472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local variation in expression of pro- and antithrombotic factors in vascular endothelium of human autopsy brain.
    Tohgi H; Utsugisawa K; Yoshimura M; Nagane Y; Ukitsu M
    Acta Neuropathol; 1999 Aug; 98(2):111-8. PubMed ID: 10442549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycation does not alter LDL-induced secretion of tissue plasminogen activator and plasminogen activator inhibitor-1 from human aortic endothelial cells.
    Klein RL; Semler AJ; Baynes JW; Thorpe SR; Lyons TJ; Jenkins AJ
    Ann N Y Acad Sci; 2005 Jun; 1043():379-89. PubMed ID: 16037259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity.
    Li Y; Chen H; Tan J; Wang X; Liang H; Sun X
    Eur J Clin Invest; 1998 Dec; 28(12):1050-4. PubMed ID: 9893018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
    Blann AD; Dobrotova M; Kubisz P; McCollum CN
    Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of venous insufficiency is related to the density of microvascular deposition of PAI-1, uPA and von Willebrand factor.
    Kolbach DN; Hamulyák K; Prins MH; Neumann HA; Cleutjens JP
    Vasa; 2004 Feb; 33(1):19-24. PubMed ID: 15061043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine 3':5'-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.
    Hegeman RJ; van den Eijnden-Schrauwen Y; Emeis JJ
    Thromb Haemost; 1998 Apr; 79(4):853-8. PubMed ID: 9569204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ; Wu YH; Liu CF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells.
    Huang LQ; Whitworth JA; Chesterman CN
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):438-45. PubMed ID: 8589211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endothelial storage granule for tissue-type plasminogen activator.
    Emeis JJ; van den Eijnden-Schrauwen Y; van den Hoogen CM; de Priester W; Westmuckett A; Lupu F
    J Cell Biol; 1997 Oct; 139(1):245-56. PubMed ID: 9314543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sampling from a peripheral venous catheter compared to repeated venepunctures on markers of coagulation, inflammation, and endothelial function.
    Espenhain Landgrebe L; Schlosser Mose L; Palarasah Y; Sidelmann JJ; Bladbjerg EM
    Scand J Clin Lab Invest; 2019 Dec; 79(8):584-589. PubMed ID: 31631713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of radiocontrast agents on human umbilical vein endothelial cells: cytotoxicity and modulators of thrombogenicity.
    Fauser C; Ullisch EV; Kübler W; Haller C
    Eur J Med Res; 2001 Nov; 6(11):465-72. PubMed ID: 11726305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.